Taken together, these data demonstrate that DNMT3A is a MEG3 downstream gene and that MEG3 probably plays crucial roles in inhibiting tumor growth by downregulating DNMT3A via the MDM2/RB signaling pathway in AML cells in the absence of p53. The gene discussed is MDM2; the disease is neoplasm.